MI-319

N/A

Report date: 2023/05/05 17:35:31
NME

Base Information

Drug NameMI-319
Drug Alias NameMI-319
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionp53-binding protein Mdm-2 inhibitorsTumor protein p53 stimulants
Targetsp53-binding protein Mdm-2Tumor protein p53
Therapy Area/IndicationsLymphoma, Follicular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Michigan
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of Michigan
Active IndicationsN/A
Inactive IndicationsLymphoma, Follicular

Other Information

ATC CodeN/A
Related LinksN/A